UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041835
Receipt number R000047474
Scientific Title Novel diagnostics for allergy in infants with high risk of developing food allergy: Qualitative and quantitative measurement of specific IgE
Date of disclosure of the study information 2020/09/18
Last modified on 2023/09/21 11:58:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prediction of food allergy development

Acronym

Prediction of food allergy

Scientific Title

Novel diagnostics for allergy in infants with high risk of developing food allergy: Qualitative and quantitative measurement of specific IgE

Scientific Title:Acronym

Prediction of food allergy by qualitative evaluation of specific IgE

Region

Japan


Condition

Condition

Food allergy

Classification by specialty

Clinical immunology Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Testing whether IgE quality and quantity and class switch patterns predict the development of food allergy.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Relationship between food allergy development and IgE avidity

Key secondary outcomes

Relationship between food allergy development and immunoglobulin class switch


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 months-old <=

Age-upper limit

8 months-old >

Gender

Male and Female

Key inclusion criteria

1) diagnosis of atopic dermatitis
2) less than 5 months old before start of weaning food
3) less than 8 months old and suspected egg or milk allergy
4) less than 8 months old and higher than 7 at EASI score

Key exclusion criteria

1) congenital immune deficiency
2) use of suppressants
3) any severe underlying disease

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Takao
Middle name
Last name Fujisawa

Organization

Mie National Hospital

Division name

Department of Clinical Research

Zip code

514-0125

Address

357 Ozato-Kubota, Tsu, Mie, Japan

TEL

059-232-2531

Email

eosinophilosophy@gmail.com


Public contact

Name of contact person

1st name Takafumi
Middle name
Last name Takase

Organization

Mie National Hospital

Division name

Department of Pediatrics

Zip code

514-0125

Address

357 Ozato-Kubota, Tsu, Mie, Japan

TEL

059-232-2531

Homepage URL


Email

takatak817@gmail.com


Sponsor or person

Institute

Department of Clinical Research, Mie National Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Mie National Hospital

Address

357 Ozato-Kubota, Tsu, Mie, Japan

Tel

059-232-2531

Email

mieclinicalresearch@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構三重病院(三重県)、徳島大学先端酵素学研究所(徳島県)


Other administrative information

Date of disclosure of the study information

2020 Year 09 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

101

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 09 Month 18 Day

Date of IRB

2020 Year 08 Month 18 Day

Anticipated trial start date

2020 Year 09 Month 18 Day

Last follow-up date

2023 Year 09 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Infants under 5 months of age with a diagnosis of atopic dermatitis before weaning are enrolled in the study. Blood samplings are performed at 3-5 months of age, 6-8 months of age, 9-11 months of age, and 12-14 months of age. Severity of atopic dermatitis and weaning diet history are also recorded at the same time points. At 12-14 months,oral food challenge tests of eggs and milk are performed to confirm presence/absence of food allergy. IgE antibody quality and quantity and class switch patterns are analysed to test whether the biomarkers predict food allergy development.


Management information

Registered date

2020 Year 09 Month 18 Day

Last modified on

2023 Year 09 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047474


Research Plan
Registered date File name
2021/01/14 20201211臨床研究計画書ハイリスク乳児_エントリー変更 .docx

Research case data specifications
Registered date File name

Research case data
Registered date File name